8 results about "Polygonum bistorta" patented technology

This invention relates to the field of traditional Chinese medicine technology, and more particularly to a traditional Chinese medicine composition and its application in the preparation of antifungal drugs. The composition provided by this invention comprises Dioscorea hypoglauca, Cnidium monnieri, Bistorta officinalis, Dioscorea nipponica, Murraya paniculata, Dioscorea opposita, Polygonum multiflorum, and Terminalia chebula. This composition has the effect of inhibiting the growth of superficial dermatophytes (such as Trichophyton rubrum and Candida albicans), which helps to reduce the occurrence of superficial dermatophyte infections and has the potential to be developed into a drug for treating superficial dermatophyte infections.

This invention provides a thin-layer chromatography (TLC) method for detecting and identifying Polygonum bistorta or its adulterants and their formulation granules. The TLC method for detecting Polygonum bistorta or its adulterants includes: spotting the test solution onto a silica gel G TLC plate; developing the plate using a toluene-butyl acetate-formic acid-acetic acid solution at a volume ratio of 10:(8-10):(3-5):(1-2); removing the plate; air-drying the plate; and examining it under ultraviolet light and / or spraying it with a colorimetric reagent and examining it under sunlight. This invention can effectively obtain TLC chromatograms of Polygonum bistorta and its adulterants with a greater number of significant spots. The TLC method is simple to operate, has a rapid detection time, produces a large number of fluorescent spots in the Polygonum bistorta sample, displays rich material information, and provides clear and concise results, allowing for intuitive determination of sample measurement results. The method has strong adaptability; therefore, it can effectively provide the prerequisites for quality control or subsequent identification of Polygonum bistorta and its adulterants.

The invention relates to the technical field of Mongolian medicines, discloses a Mongolian medicine composition for treating a liver-heat-type liver disease, and aims to solve the problems that when an existing Mongolian medicine scheme is used for treating complex diseases with liver parenchyma injury and liver and gall dysfunction, the synergism of liver heat clearing and liver and gall dysfunction is insufficient, and overall intervention is difficult. The Mongolian medicine composition is prepared from twenty-one medicinal materials including bunge corydalis herb, coptis chinensis, fructus gardeniae, bistort rhizome, bear gall powder, fructus choerospondiatis, radix aucklandiae, flos caryophyllata, amomum tsao-ko, myristica fragrans and the like. The traditional Chinese medicine composition is prepared by adopting a staged extraction process, comprehensively plays the effects of protecting the liver, lowering transaminase, benefiting the gallbladder, relieving jaundice and improving the gastrointestinal function, and shows better comprehensive treatment effect and safety on drug-induced, alcoholic and non-alcoholic fatty liver injuries.

This invention discloses a traditional Chinese medicine composition for the prevention and / or treatment of herpes and / or its complications. By weight, the composition comprises: 8-14 parts of Sophora flavescens, 5-11 parts of Bistorta officinalis, 9-15 parts of Rheum palmatum, 0.5-6 parts of Coptis chinensis, 1-7 parts of Forsythia suspensa, 1-7 parts of Taraxacum mongolicum, 1-7 parts of Viola yedoensis, 1-7 parts of Paeonia lactiflora, 1-7 parts of Paeonia suffruticosa, 1-7 parts of Gardenia jasminoides, 3-9 parts of Rehmannia glutinosa, 1-7 parts of Chrysanthemum indicum, 1-7 parts of Lonicera japonica, 1-7 parts of Atractylodes lancea, 0.5-6 parts of Phellodendron chinense, 0.5-1.5 parts of Cicadae periostracum, 2-8 parts of Smilax glabra, 1-7 parts of Anemarrhena asphodeloides, 1-7 parts of Ophiopogon japonicus, 0.5-6 parts of Alisma plantago-aquatica, and 1-7 parts of Gypsum fibrosum. The complications are pain and / or inflammation. This traditional Chinese medicine composition is safe, effective, and has a simple and efficient preparation method with controllable quality. It also exhibits significant analgesic and anti-inflammatory effects and can treat shingles and its sequelae.

The application provides a traditional Chinese medicine composition for treating benign nodules and a preparation method and application thereof, and belongs to the field of traditional Chinese medicines. The traditional Chinese medicine composition is prepared from raw medicinal materials in the following weight ratio: Bistorta 12-18 parts, Agrimonia pilosa 24-36 parts, Laetiporus 9.6-14.4 parts, Forsythia 16-24 parts, Platycodon 12-18 parts, Fritillaria thunbergii Miq. 16-24 parts and Begonia fimbristipula 14.4-21.6 parts. The application also provides a preparation method and application of the traditional Chinese medicine composition. The traditional Chinese medicine composition aims at the core pathogenesis of phlegm and blood stasis syndrome of tuberculosic disease, has the effects of clearing heat, resolving nodules, resolving phlegm and removing blood stasis, and has the effects of tonifying qi and supporting healthy energy, is used for treating benign nodules of the lung, thyroid or breast, achieves the effect of treating different diseases in the same way, and has the advantages of accurate curative effect, small side effect and prevention of recurrence.

This invention discloses the application of a traditional Chinese medicine composition in the preparation of drugs for the prevention and treatment of gastritis. The composition comprises the following ingredients: Astragalus membranaceus, ginseng, Atractylodes macrocephala, fermented Cordyceps militaris powder, Lycium barbarum, Hedyotis diffusa, Fagopyrum dibotrys, Bistorta officinalis, Panax notoginseng, and Caesalpinia sappan. This invention is the first to discover and confirm that this traditional Chinese medicine composition can be used to prevent or treat chronic gastritis, especially chronic atrophic gastritis. Experiments have verified that it can significantly prevent or improve the pathological state of the gastric mucosa in rats with chronic atrophic gastritis. Specifically, it can significantly increase the serum pepsinogen I / II ratio, decrease gastrin-17 levels, reverse gastric gland atrophy, and repair the morphological structure of the gastric mucosa, achieving a systematic repair of the function and structure of the CAG gastric mucosa. Furthermore, the ingredients in this traditional Chinese medicine composition are rationally combined, and no obvious toxic side effects were observed under experimental conditions, demonstrating good safety and potential for long-term use.

The present invention relates to the technical field of Mongolian medicine, and discloses a Mongolian medicine named Renqing Wugete Busan for treating Heretic lung disease. This Mongolian medicine is composed of twenty-six medicinal materials including Gentiana algida Pall., Aquilaria sinensis (Lour.) Gilg, Choerospatha eriostachya (Wall.) Miq., Santalum album Linn., Myristica fragrans Houtt., Gypsum Fibrosum, Adenophora stricta Miq., Aucklandia lappa Decne., Terminalia chebula Retz., Melia toosendan Sieb. et Zucc., Gardenia jasminoides Ellis, Sophora flavescens Ait., Potentilla discolor Bunge, Dianthus superbus Linn., Eugenia caryophyllata Thunb., Glycyrrhiza glabra Linn., Vitis vinifera L., Cyperus rotundus L., Cinnamomum cassia Presl, Punica granatum L., Carthamus tinctorius L., Ilex purpurea Hassk., Alpinia oxyphylla Miq., Piper longum L., Neptunea arthritica cumingii, Bistorta officinalis Z. in specific weight part ratios. In the formula, Vitis vinifera L. and Myristica fragrans Houtt. are monarch drugs, Ilex purpurea Hassk., Carthamus tinctorius L., Gypsum Fibrosum, Glycyrrhiza glabra Linn., Adenophora stricta Miq., Cyperus rotundus L., Choerospatha eriostachya (Wall.) Miq., Santalum album Linn., Aquilaria sinensis (Lour.) Gilg are ministerial drugs, and the rest are adjuvant and guiding drugs. The total weight part ratio of the monarch drugs to the ministerial drugs is 1:3.0 - 3.4, and the total weight part ratio of the heat-clearing medicinal materials to the stomach-warming medicinal materials among the adjuvant and guiding drugs is 1:1.1 - 1.5. The present invention realizes the synchronous regulation of the disorder of Heretic and Badagan through scientific ratio, and takes into account the treatment of lung symptoms and gastrointestinal functions.

Ascites and pleural effusion are common complications, and clinical interventions primarily based on symptomatic treatment often result in poor prognoses. Guided by the new theory of "inflammation-cancer" transformation, this invention discloses a traditional Chinese medicine composition for the prevention and treatment of ascites and pleural effusion, along with its preparation methods for internal and external use. The composition comprises the following medicinal materials in parts by weight: Codonopsis pilosula 3-20 parts, Atractylodes macrocephala 3-20 parts, Cinnamomum cassia 3-18 parts, Trichosanthes kirilowii 3-18 parts, Panax notoginseng 3-12 parts, Lobelia chinensis 3-15 parts, Polygonum bistorta 3-15 parts, Euphorbia helioscopia 3-15 parts, and Lepidium apetalum 3-15 parts. This traditional Chinese medicine composition possesses the effects of strengthening the body's resistance, removing blood stasis, detoxifying, eliminating dampness, promoting diuresis, and reducing swelling. It is effective in preventing and treating inflammatory and malignant ascites and pleural effusion, as well as the associated symptoms such as dyspnea, chest pain, cough, loss of appetite, abdominal pain, abdominal distension, fatigue, and night sweats. It can be prepared as a decoction, granules, pills, capsules, or powder. This invention helps promote the absorption and drainage of pleural and peritoneal effusions, reduce inflammation and fight cancer, adjust and restore the physiological functions of internal organs, and improve the quality of life of patients.